SEC 13F Intelligence

Rikoon Group, LLC / ABT

Rikoon Group, LLC’s Abbott Laboratories Position

Does Rikoon Group, LLC own Abbott Laboratories (ABT)? Yes — 62.4K shares worth $7M (+1.99% of its 13F portfolio) as of Q1 2021, down from 63.2K shares the prior filed quarter.

Position Value
$7M
Q1 2021
Shares
62.4K
% of Portfolio
+1.99%
Quarters Held
10
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $5MQ4 ’18Q1 ’19: $5MQ2 ’19: $5MQ2 ’19Q3 ’19: $5MQ4 ’19: $5MQ4 ’19Q1 ’20: $5MQ2 ’20: $6MQ2 ’20Q3 ’20: $7MQ4 ’20: $7MQ4 ’20Q1 ’21: $7Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202162.4K$7M+1.99%
Q4 202063.2K$7M+1.93%
Q3 202063.1K$7M+2.12%
Q2 202063.4K$6M+1.94%
Q1 202061.8K$5M+2.02%
Q4 201961.5K$5M+1.84%
Q3 201961.8K$5M+1.91%
Q2 201961.8K$5M+1.93%
Q1 201962.8K$5M+1.87%
Q4 201862.7K$5M+1.88%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rikoon Group, LLC’s full portfolio or all institutional holders of ABT.